from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1171/-

LFCtreatmentdescriptionclass of inhibitor

1.012

Amikacinug/mL Amikacintranslation

0.237

Cap5-10ug/mL Capreomycintranslation

1.316

Rox10-50 ug/mL Roxithromycintranslation

0.439

SM2-5 ug/mL Streptomycintranslation

0.668

Tet5-10 ug/mL Tetracyclinetranslation

0.182

Rif0.2-5ug/mL Rifampicintranscription

0.582

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.193

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.446

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.269

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.781

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.758

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.349

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.288

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.601

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.242

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.830

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.592

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.540

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.822

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.594

KCN5-20 ug/mL Potassium cyaniderespiration

-0.224

NaN30.2-2 mM Sodium aziderespiration

0.382

Nigericin50 uM Nigericinrespiration

-0.653

TRC10-150 ug/mL Triclosanrespiration

-0.475

TRZ10-25 ug/mL Thioridazinerespiration

-0.846

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.082

menadione6-10 ug/mL Menadionerespiration

0.271

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.043

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.219

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.103

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.587

NRP_1Non-replicating persistence stage 1dosRassociated

0.162

Amp0.2mg/mL AmpicillincellWall

-0.635

Cephalexin20-100 ug/mL CephalexincellWall

1.144

Cerulenin0.32-5 ug/mL CerulenincellWall

0.326

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.473

EMB10-20 ug/mL EthambutolcellWall

-0.196

Eta12-40 ug/mL EthionamidecellWall

0.044

INH0.2-0.4 ug/mL IsoniazidcellWall

0.208

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.316

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.496

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.649

BZA0.12 mg/mL BenzamidearomaticAmides

0.141

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.388

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.592

H2O24 mM hydrogen peroxideDNAdamaging

0.012

Levo10 ug/mL LevofloxacinDNAdamaging

-0.237

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.677

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.590

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.094

UVUV-irradiationDNAdamaging

-0.340

ARP41-4 ug/mL Antitubercular compound ARP4?

0.704

Antimycin12.5-50 ug/mL Antimycin A?

-0.681

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.517

PA_110-50 ug/mL Antitubercular compound PA-1?

0.276

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.385

PA8240.2-2 ug/mL PA-824?

-1.548

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.501

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.274

Verapamil50 uM Verapamil?

-0.185

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.809

methoxatin10-20 ug/mL Methoxatin?